Vanderbilt-Ingram Mourns Longtime Patient Advocate

Robb Kerr, a dedicated Vanderbilt-Ingram patient advocate, died at his home in Nashville on Sept. 29, 2008. He was 43.

Soon after his diagnosis of advanced (stage IV) colorectal cancer in 2002, Robb became involved in clinical trials at the Cancer Center, participating in five clinical trials during his six-year battle. Robb became a patient advocate, sharing his clinical trials experiences with other patients.

Through his experience, Robb also became a passionate supporter of cancer research and was one of the first individuals to become a research advocate for the gastrointestinal cancer SPORE (Specialized Program of Research Excellence). As a research advocate, Robb participated in the design and oversight of cancer research, helped design patient consent forms, and shared his insights from participating in clinical trials with researchers.

Robb gave of himself tirelessly, reaching out to other patients informally in the clinic to share his experiences and support them in their journey. He also spoke out for the needs of Tennesseans without insurance and those who lost TennCare, working with advocacy organizations for change.

“Robb’s legacy to cancer research and patient advocacy will long be remembered and his spirit will live on in the hearts of all who were touched by him,” said Jane Kennedy, MSSW, manager of Patient Advocacy in the Office of Patient and Community Education at Vanderbilt-Ingram.

– by Melissa Marino